Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperlipoproteinemia type 3: the forgotten phenotype.

Current atherosclerosis reports - 1 Sept 2014

Hopkins Paul N, Brinton Eliot A, Nanjee M Nazeem

Abstract excerpt

Hyperlipoproteinemia type 3 (HLP3) is caused by impaired removal of triglyceride-rich lipoproteins (TGRL) leading to accumulation of TGRL remnants with abnormal composition. High levels of these remnants, called β-VLDL, promote lipid deposition in tuberous xanthomas, atherosclerosis, premature coronary artery disease, and early myocardial infarction. Recent genetic and molecular studies suggest more genes than...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Genetic Predisposition to Disease
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hyperlipoproteinemia Type III

Share to Lipid metabolism and disorders

Share to Lipoproteins

Share to Phenotype

Share to Triglycerides

Source

Identifiers

PMID: 25079293
DOI: 10.1007/s11883-014-0440-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hyperlipoproteinemia type 3: the forgotten phenotype.PMID 25079293Read ↗

Dysbetalipoproteinemia is overlooked and dangerous.Semantic proximity Read ↗

Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxesSemantic proximity Read ↗

Familial hypobetalipoproteinemia: genetics and metabolism.Semantic proximity Read ↗

Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.Semantic proximity Read ↗

PNPLA3-I148M is a Neomorph that Interferes with Two Primary Hepatic Triglyceride Clearance PathwaysSemantic proximity Read ↗

Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm.Semantic proximity Read ↗

Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families.Semantic proximity Read ↗

APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required.Semantic proximity Read ↗

Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE DeficiencySemantic proximity Read ↗

Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.Semantic proximity Read ↗

Diagnosis of remnant hyperlipidaemia.Semantic proximity Read ↗

Human hepatic lipase mutations and polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.